publication venue for
- Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study.. 24:117. 2025
- Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.. 23:352. 2024
- Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes.. 23:325. 2024
- The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis. 23:72. 2024
- High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies. 22:300. 2023
- CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. 22:59. 2023
- General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial. 22:52. 2023
- Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. 21:12. 2022
- Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout. 21:133. 2022
- A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes. 21:158. 2022
- Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND. 20:194. 2021
- The prediction of Metabolic Syndrome alterations is improved by combining waist circumference and handgrip strength measurements compared to either alone. 20:68. 2021
- Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial. 19:175. 2020
- Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis. 19:199. 2020
- Cognitive function in adolescence and the risk for premature diabetes and cardiovascular mortality in adulthood. 17:154. 2018
- Group-based activities with on-site childcare and online support improve glucose tolerance in women within 5 years of gestational diabetes pregnancy. 13:104. 2014
- Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. 12:170. 2013
- Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. 7:5. 2008